Literature DB >> 16814597

Herpesvirus assembly: a tale of two membranes.

Thomas C Mettenleiter1, Barbara G Klupp, Harald Granzow.   

Abstract

Herpes virions are amongst the most complex virus particles: they comprise in excess of thirty virally encoded proteins, and also contain cellular components. Capsid formation and the cleavage and encapsidation of replicated viral DNA occur in the nucleus and resemble similar processes in tailed dsDNA (double-stranded DNA) bacteriophages, which indicates they might have common ancestry. In contrast, final virion maturation takes place in the cytoplasm. Nucleocapsids gain access to this compartment by envelopment at the inner nuclear membrane, which involves the interaction between viral and cellular proteins in order to locally alter nuclear architecture. Fusion of the primary viral envelope with the outer nuclear membrane results in translocation of the nucleocapsid to the cytoplasm. Here, the majority of the tegument - a structure, composed of a multitude of different proteins, that links the capsid and the envelope - is added to nucleocapsids, which obtain their final envelope by budding into glycoprotein-containing Golgi-derived vesicles. Thus, herpesvirus morphogenesis proceeds in two different cellular compartments, involving different viral and cellular proteins.

Entities:  

Mesh:

Year:  2006        PMID: 16814597     DOI: 10.1016/j.mib.2006.06.013

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  125 in total

1.  Random transposon-mediated mutagenesis of the essential large tegument protein pUL36 of pseudorabies virus.

Authors:  Britta S Möhl; Sindy Böttcher; Harald Granzow; Walter Fuchs; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Wnt signaling in neuromuscular junction development.

Authors:  Kate Koles; Vivian Budnik
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06       Impact factor: 10.005

3.  The capsid protein encoded by U(L)17 of herpes simplex virus 1 interacts with tegument protein VP13/14.

Authors:  Luella D Scholtes; Kui Yang; Lucy X Li; Joel D Baines
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Glycoprotein M of herpes simplex virus 1 is incorporated into virions during budding at the inner nuclear membrane.

Authors:  Joel D Baines; Elizabeth Wills; Robert J Jacob; Janice Pennington; Bernard Roizman
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 5.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

6.  Efficient incorporation of tegument proteins pUL46, pUL49, and pUS3 into pseudorabies virus particles depends on the presence of pUL21.

Authors:  Kathrin Michael; Barbara G Klupp; Axel Karger; Thomas C Mettenleiter
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope.

Authors:  Vahbiz Jokhi; James Ashley; John Nunnari; Akiko Noma; Naoto Ito; Noriko Wakabayashi-Ito; Melissa J Moore; Vivian Budnik
Journal:  Cell Rep       Date:  2013-04-11       Impact factor: 9.423

8.  Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production.

Authors:  Chung-Pei Lee; Yu-Hao Huang; Su-Fang Lin; Yao Chang; Yu-Hsin Chang; Kenzo Takada; Mei-Ru Chen
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Meeting of conventional and unconventional pathways at the TGN.

Authors:  Gaudeline Rémillard-Labrosse; Roger Lippé
Journal:  Commun Integr Biol       Date:  2009-09

10.  Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids.

Authors:  Ken Sagou; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.